MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

12 Feb 2026 Evaluate
Revenue showed a marginal decline at Rs. 0.93 millions. For the quarter ended December 2025, as compared to corresponding quarter of last year.The Total revenue for the quarter ended December 2025 of  Rs. 1.15  millions  grew by 538.89% from Rs. 0.18 millions.Operating Profit reported a sharp decline to 1.53 millions from 1.55 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 0.93 0.96 -3.12 2.78 5.15 -46.02 6.11 5.55 10.09
Other Income 4.90 4.34 12.90 15.63 14.01 11.56 20.09 19.92 0.85
PBIDT 1.53 1.55 -1.29 5.75 7.68 -25.13 10.58 9.10 16.26
Interest 0.01 0.00 0.00 0.03 0.00 0.00 0.01 0.00 0.00
PBDT 1.52 1.55 -1.94 5.72 7.68 -25.52 10.57 9.10 16.15
Depreciation 0.25 0.24 4.17 0.75 0.72 4.17 0.98 0.98 0.00
PBT 1.27 1.31 -3.05 4.97 6.96 -28.59 9.59 8.12 18.10
TAX 0.12 1.13 -89.38 0.98 3.10 -68.39 6.42 1.62 296.30
Deferred Tax -0.20 1.42 -114.08 -0.30 2.09 -114.35 2.02 1.49 35.57
PAT 1.15 0.18 538.89 3.99 3.86 3.37 3.17 6.50 -51.23
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 164.52 161.46 1.89 206.83 149.13 38.70 173.16 163.96 5.61
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..